The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

HIV (human immunodeficiency virus) remains a significant global health challenge, affecting millions of people worldwide. While advancements in medical science have led to better management of the ...

Add Yahoo as a preferred source to see more of our stories on Google. Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or ...

Gilead has developed a 1-every-6-month injection to prevent HIV. The medication will sell for $14,000 a shot. With numerous proposed major cuts to Medicaid and the Affordable Care Act in congress, ...

Deputy President welcomes rollout of HIV prevention injection Deputy President Paul Mashatile has hailed South Africa’s upcoming rollout of Lenacapavir as a potential game-changer in the country’s ...

The landscape of HIV prevention has undergone a profound transformation with significant advancements in medical interventions and a deeper understanding of how the virus spreads. These developments ...

Many changes regarding Delaware's Ryan White HIV/AIDS Program are slated to take effect April 1. Here's what you need to know ...

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in ...

"Pre-exposure prophylaxis (PrEP) is the most important concept in the [HIV] prevention field today," Robert Grant told the Infectious Disease Society of America at their annual meeting in San Diego.